These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3030814)

  • 1. The three-dimensional similarity between a dimeric antiparallel extended structure and a beta-turn folded form of enkephalin.
    Doi M; Tanaka M; Ishida T; Inoue M
    FEBS Lett; 1987 Mar; 213(2):265-8. PubMed ID: 3030814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. II. Models of mu- and delta-receptor-bound structures for analogues containing Phe4.
    Nikiforovich GV; Golbraikh AA; Shenderovich MD; Balodis J
    Int J Pept Protein Res; 1990 Sep; 36(3):209-18. PubMed ID: 2177733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel side-chain-linked antiparallel cyclic dimer of enkephalin.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    FEBS Lett; 1985 Oct; 191(2):231-4. PubMed ID: 2996933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of [Met5] and [(4-bromo)Phe4,Met5]enkephalins: formation of a dimeric antiparallel beta-structure.
    Doi M; Tanaka M; Ishida T; Inoue M; Fujiwara T; Tomita K; Kimura T; Sakakibara S; Sheldrick GM
    J Biochem; 1987 Feb; 101(2):485-90. PubMed ID: 3584096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-dynamics simulations of [Met5]- and [D-Ala2,Met5]-enkephalins. Biological implication of monomeric folded and dimeric unfolded conformations.
    Ishida T; Yoneda S; Doi M; Inoue M; Kitamura K
    Biochem J; 1988 Oct; 255(2):621-8. PubMed ID: 3202835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the delta-receptor-bound conformation of enkephalin.
    Nikiforovich GV; Balodis J
    FEBS Lett; 1988 Jan; 227(2):127-30. PubMed ID: 2828117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for specific recognition of mu or delta opiate receptors.
    Fournie-Zaluski MC; Gacel G; Maigret B; Premilat S; Roques BP
    Mol Pharmacol; 1981 Nov; 20(3):484-91. PubMed ID: 6276710
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental simulation of the environment of the delta opioid receptor. A 500 MHz study of enkephalins in CDCl3.
    Beretta CA; Parrilli M; Pastore A; Tancredi T; Temussi PA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):456-62. PubMed ID: 6329204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).
    Maigret B; Fournie-Zaluski MC; Roques B; Premilat S
    Mol Pharmacol; 1986 Mar; 29(3):314-20. PubMed ID: 3005838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF; Goldstein A
    Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.
    Mihara H; Lee S; Shimohigashi Y; Aoyagi H; Kato T; Izumiya N; Costa T
    Biochem Biophys Res Commun; 1986 May; 136(3):1170-6. PubMed ID: 3013169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selectivity of [D-Ala2-O-benzyl-Ser5]-enkephalin on mu and delta opiate receptor subtypes].
    Ji XQ; Zhang HL; Liu S; Zou G
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):3-5. PubMed ID: 2986407
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs.
    Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y
    J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray diffraction studies of enkephalins. Crystal structure of [(4'-bromo) Phe4,Leu5]enkephalin.
    Ishida T; Kenmotsu M; Mino Y; Inoue M; Fujiwara T; Tomita K; Kimura T; Sakakibara S
    Biochem J; 1984 Mar; 218(3):677-89. PubMed ID: 6721829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for delta opioid receptor binding.
    Mosberg HI; Omnaas JR; Goldstein A
    Mol Pharmacol; 1987 Jun; 31(6):599-602. PubMed ID: 3037296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.